WCLC 2025 - Posters & ePosters-P3.12.71 Efficacy and Safety of Pralsetinib in Patients With Advanced Ret Fusion-Positive NSCLC: Phase 1/2 ARROW Study Final Data

P3.12.71 Efficacy and Safety of Pralsetinib in Patients With Advanced Ret Fusion-Positive NSCLC: Phase 1/2 ARROW Study Final Data

Asset Subtitle

Aaron Mansfield

Meta Tag

Speaker Aaron Mansfield

Topic Metastatic Non-small Cell Lung Cancer – Targeted Therapy